Phase 3 Dyslipidaemia Clinical Trials
2 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–2 of 2 trials
Recruiting
Phase 2Phase 3
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of AZD0780 in Participants With Dyslipidaemia
Dyslipidaemia
AstraZeneca360 enrolled43 locationsNCT06834932
Completed
Phase 3
A trial to determine: a) the effectiveness of fibre supplement, alpha-cyclodextrin, on cholesterol control in overweight and obese participants with pre diabetes b) the effectiveness of ginseng derivative, Compound K, on blood sugar control in overweight and obese participants with pre diabetes
ObesityOverweightDyslipidaemia
The University of Sydney400 enrolled2 locationsACTRN12614001302640